Literature DB >> 8852981

Donor-to-host transmission of Mycoplasma hominis in lung allograft recipients.

R Gass1, J Fisher, D Badesch, M Zamora, A Weinberg, H Melsness, F Grover, J G Tully, F C Fang.   

Abstract

Mycoplasma hominis is a significant pathogen in immunocompromised hosts, particularly organ transplant recipients. We describe two recipients of lung allografts from the same donor who had M. hominis pleuropulmonary infection during the immediate postoperative period. The most likely source of infection in these cases was the donor's respiratory tract. The slow-growing pinpoint colonies formed by M. hominis on routine bacterial culture medium may be easily overlooked and should be subcultured to mycoplasmal medium for definitive identification. The recommended management of this infection consists of drainage and antimicrobial therapy with tetracycline, clindamycin, or a fluoroquinolone. This report highlights the potential for M. hominis to be transmitted from donor to recipient during organ transplantation.

Entities:  

Mesh:

Year:  1996        PMID: 8852981     DOI: 10.1093/clinids/22.3.567

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Impact of Screening and Treatment of Ureaplasma species on Hyperammonemia Syndrome in Lung Transplant Recipients: A Single Center Experience.

Authors:  Scott C Roberts; Ankit Bharat; Chitaru Kurihara; Rade Tomic; Michael G Ison
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

Review 2.  Hyperammonemia syndrome in immunosuppressed individuals.

Authors:  Scott C Roberts; Waleed Malik; Michael G Ison
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

Review 3.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

4.  Mycoplasma hominis-associated parapharyngeal abscess following acute Epstein-Barr virus infection in a previously immunocompetent adult.

Authors:  Karina J Kennedy; Sam Prince; Timothy Makeham
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

Review 5.  An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients.

Authors:  O C Smibert; M A Paraskeva; G Westall; Greg Snell
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

Review 6.  Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety.

Authors:  J B Baseman; J G Tully
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

7.  Two Cases of Fatal Hyperammonemia Syndrome due to Mycoplasma hominis and Ureaplasma urealyticum in Immunocompromised Patients Outside Lung Transplant Recipients.

Authors:  Cima Nowbakht; Angelina R Edwards; David F Rodriguez-Buritica; Andrea M Luce; Pratik B Doshi; Aleksandra De Golovine; John S Bynon; Masayuki Nigo
Journal:  Open Forum Infect Dis       Date:  2019-03-04       Impact factor: 3.835

8.  Mycoplasma hominis hematoma infection in patient following kidney transplant.

Authors:  Mackenzie A Dolan; Zachary S Elliott; Christopher J Arnold
Journal:  IDCases       Date:  2021-06-12

9.  Cardiothoracic Transplant Recipient Mycoplasma hominis: An Uncommon Infection with Probable Donor Transmission.

Authors:  Rahul Sampath; Robin Patel; Scott A Cunningham; Sana Arif; Richard C Daly; Andrew D Badley; Mark E Wylam
Journal:  EBioMedicine       Date:  2017-04-19       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.